Inhibitory effect of interleukin-2 on the histamine release from rat peritoneal mast cells in association with the production of lipocortin-I

  • Kenji Tasaka


It has been shown that the development and growth of mast cells are dependent upon interleukin-3 (IL-3), IL-4 and IL-9 (IhIe et al., 1983; Schmitt et al., 1987; Hultner et al., 1990). On the other hand, it has also been reported that histamine release from mast cells or basophils is induced or potentiated by several cytokines, such as IL - 1 α, IL - 1 β, IL-2, IL-3, IL-4 and granulocyte-macrophage colony stimulating factor (GM-CSF) (Massey et al., 1989; Levi-Schaffer et al., 1991; Haak-Frendscho et al., 1988). However, most of these studies are carried out using basophils and mucosal type mast cells, but not with connective tissue type mast cells. Levi-Schaffer et al. (1991) reported that IL-2, IL-3 and IL-4 enhanced both the basal and anti-IgE-mediated histamine release from rat and murine peritoneal mast cells co-cultured with fibroblasts. Moreover, there has been no demonstration about the inhibitory effect of cytokine on the histamine release from mast cells.


Mast Cell Histamine Release 45Ca Uptake Peritoneal Mast Cell Leucine Uptake 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Emilie D., Karray S., Merle-Beral H., Debre P. and Galanaud P. (1988) Induction of differentiation in human leukemic B cells by interleukin 2 alone: Differential effect on the expression of μ, and J chain genes. Eur. J. Immunol., 18: 1479–1483PubMedCrossRefGoogle Scholar
  2. Espinoza-Delgado I., Longo D.L., Gusella G.L. and Varesio L. (1990) IL-2 enhances c-fms expression in human monocytes. J. Immunol., 145: 1137–1143PubMedGoogle Scholar
  3. Flower R.J. (1988) Lipocortin and the mechanism of action of the glucocorticoids. Br. J. Pharmacol., 94: 987–1015PubMedGoogle Scholar
  4. Haak-Frendscho M., Arai N. and Arai K. (1988) Human recombinant granulocyte- macrophage colony-stimulating factor and interleukin-3 cause basophil histamine release. J. Clin. Invest., 82: 17–20PubMedCrossRefGoogle Scholar
  5. Hultner L., Druez C., Moeller J., Uyttenhove C., Schmitt E., Rude E., Dormer P. and Van Snick J. (1990) Mast cell growth-enhancing activity (MEA) is structurally related and functionally identical to the novel mouse T cell growth factor P40/TCGFIII (interleukin 9). Eur. J. Immunol., 20: 1413–1416PubMedCrossRefGoogle Scholar
  6. Ihle J.N., Keller J., Oroszlan S., Henderson L.E., Copeland T.D., Fitch F, Prystowsky M. B., Goldwasser E., Schrader J.W., Palaszynski E., Dy M. and Lebel B. (1983) Biologic properties of homogeneous interleukin 3. I. Demonstration of WEHI-3 growth factor activity, mast cell growth activity, P cell-stimulating factor activity, colony-stimulating factor activity, and histamine-producing cell-stimulating factor activity. J. Immunol., 131: 282–287PubMedGoogle Scholar
  7. Izushi K., Shirasaka T., Chokki M. and Tasaka K. (1992) Phosphorylation of smg p21B in rat peritoneal mast cells in association with histamine release inhibition by dibutyryl-cAMP. FEBS Lett., 314: 241–245PubMedCrossRefGoogle Scholar
  8. Levi-Schaffer F., Segal V. and Shalit M. (1991) Effect of interleukins on connective tissue type mast cells co-cultured with fibroblasts. Immunology, 72: 174–180PubMedGoogle Scholar
  9. Machoczek K., Fischer M. and Soling H.-D. (1989) Lipocortin I and lipocortin II inhibit phosphoinositide- and polyphosphoinositide-specific phospholipase C. The effect results from interaction with the substrates. FEBS Lett., 251: 207–212PubMedCrossRefGoogle Scholar
  10. Maggiano M., Cotta F., Castellino F., Ricci R., Valitutti S., Larocca L.M. and Musiani P. (1990) Interleukin-2 receptor expression in human mast cells and basophils. Int. Arch. Allergy Appl. Immunol., 91: 8–14PubMedCrossRefGoogle Scholar
  11. Massey A.W., Randall C.T., Kagey J.A., MacDonald M.S., Gillis S., Allison C.A. and Lichtenstein M.L. (1989) Recombinant human IL-1 α and -1 β potentiate IgE-mediated histamine release from human basophils. J. Immunol., 143: 1875–1880PubMedGoogle Scholar
  12. Pittet D., Lew D.P., Mayr G.W., Monod A. and Schlegel W. (1989) Chemoattractant receptor promotion of Ca2+ influx across the plasma membrane of HL-60 cells. A role for cytosolic free calcium elevations and inositol 1, 3, 4, 5-tetrakisphosphate production. J. Biol. Chem., 264: 7251–7261PubMedGoogle Scholar
  13. Sabath D.E., Broome H.E. and Prystowsky M.B. (1990) Glyceraldehyde-3-phosphate dehydrogenase mRNA is a major interleukin 2-induced transcript in a cloned T-helper lymphocyte. Gene, 91: 185–191PubMedCrossRefGoogle Scholar
  14. Sautebin L., Camuccio R., Ialenti A. and Di Rosa M. (1992) Lipocortin and vasocortin: Two species of anti-inflammetory proteins mimicking the effects of glucocorticoids. Pharmacol. Res., 25: 1–12PubMedCrossRefGoogle Scholar
  15. Schmitt E., Fassbender B., Beyreuther K., Spaeth E., Schwarzkopf R. and Ruede E. (1987) Characterization of a T cell-derived lymphokine that acts synergistically with IL3 on the growth of murine mast cells and is identical with IL4. Immunobiology, 174: 406–419PubMedCrossRefGoogle Scholar
  16. Smyth M.J., Ortaldo J.R., Bere W., Yagita H., Okumura K. and Young H.A. (1990) IL-2 and IL-6 synergize to augment the pore-forming protein gene expression and cytotoxic potential of human peripheral blood T cells. J. Immunol., 145: 1159–1166PubMedGoogle Scholar
  17. Tasaka K., Mio M. and Okamoto M. (1986) Intracellular calcium ion release induced by histamine releasers and its inhibition by some antiallergic drugs. Ann. Allergy, 56: 464–469PubMedGoogle Scholar
  18. Tasaka K., Sugimoto Y. and Mio M. (1990) Sequential analysis of histamine release and intracellular Ca2+ release from murine mast cells. Int. Arch. Allergy Appl. Immunol., 91: 211–213PubMedCrossRefGoogle Scholar
  19. Tasaka K., Mio M., Fujisawa K. and Aoki I. (1991) Role of microtubules on Ca2+ release from the endoplasmic reticulum and associated histamine release from rat peritoneal mast cells. Biochem. Pharmacol., 41: 1031–1037PubMedCrossRefGoogle Scholar
  20. Waldmann A. T. (1991) The interleukin-2 receptor. J. Biol. Chem., 286: 2681–2684Google Scholar
  21. Weber G. and Ferber E. (1990) Selective inhibition of phospholipase A2 by different lipocortins. J. Biol. Chem., 371: 725–731Google Scholar
  22. White M.V., Igarashi Y., Lundgren J.D., Shelhamer J. and Kaliner M. (1991) Hydrocortisone inhibits rat basophilic leukemia cell mediator release induced by neutrophil-derived histamine releasing activity as well as by anti-IgE. J. Immunol., 147: 667–673PubMedGoogle Scholar

Copyright information

© Springer-Verlag Tokyo 1994

Authors and Affiliations

  • Kenji Tasaka
    • 1
  1. 1.The Department of Pharmacology in the Faculty of Pharmaceutical SciencesOkayama UniversityOkayamaJapan

Personalised recommendations